AAB
GILD icon

ABN AMRO Bank’s Gilead Sciences GILD Stock Holding History

ABN AMRO Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5M Sell
195,724
-27,117
-12% -$3.8M 0.3% 59
2025
Q4 		$27.3M Buy
222,841
+176,750
+383% +$21.5M 0.26% 60
2025
Q3 		$5.14M Buy
+46,091
New +$5.24M 0.05% 112
2024
Q1 		– Sell
-8,194
Closed -$665K – 157
2023
Q4 		$665K Hold
8,194
– – 0.01% 128
2023
Q3 		$613K Buy
8,194
+576
+8% +$44.3K 0.01% 122
2023
Q2 		$587K Buy
+7,618
New +$608K 0.01% 119

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ABN AMRO Bank's GILD Position: Q1 2026 in Review

ABN AMRO Bank reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $3.8M and leaving 195,724 shares worth $27.5M. The position accounts for 0.3% of the portfolio, ranked #59.

ABN AMRO Bank first reported a position in GILD in Q2 2023 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • ABN AMRO Bank held 195,724 shares of Gilead Sciences worth $27.5M as of Q1 2026.
  • ABN AMRO Bank sold 27,117 Gilead Sciences shares in Q1 2026, an estimated $3.8M.
  • Gilead Sciences made up 0.3% of ABN AMRO Bank's portfolio in Q1 2026, its #59 holding.
  • ABN AMRO Bank first reported a position in Gilead Sciences in Q2 2023 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.